Nathalie Cartier-Lacave to Humans
This is a "connection" page, showing publications Nathalie Cartier-Lacave has written about Humans.
Connection Strength
0.062
-
Cartier-Lacave N, Ali R, Yl?-Herttuala S, Kato K, Baetschi B, Lovell-Badge R, Naldini L, Thrasher A. Debate on Germline Gene Editing. Hum Gene Ther Methods. 2016 08; 27(4):135-42.
Score: 0.020
-
Cartier N, Aubourg P. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy. Brain Pathol. 2010 Jul; 20(4):857-62.
Score: 0.013
-
Cartier N, Hacein-Bey-Abina S, Von Kalle C, Bougn?res P, Fischer A, Cavazzana-Calvo M, Aubourg P. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector]. Bull Acad Natl Med. 2010 Feb; 194(2):255-64; discussion 264-8.
Score: 0.013
-
Souchet B, Audrain M, Alves S, Fol R, Tada S, Orefice NS, Potier B, Dutar P, Billard JM, Cartier N, Braudeau J. Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia. J Prev Alzheimers Dis. 2022; 9(2):338-347.
Score: 0.007
-
Zerah M, Piguet F, Colle MA, Raoul S, Deschamps JY, Deniaud J, Gautier B, Toulgoat F, Bieche I, Laurendeau I, Sondhi D, Souweidane MM, Cartier-Lacave N, Moullier P, Crystal RG, Roujeau T, Sevin C, Aubourg P. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates. Hum Gene Ther Clin Dev. 2015 Jun; 26(2):113-24.
Score: 0.005
-
Sevin C, Cartier-Lacave N, Aubourg P. Gene therapy in metachromatic leukodystrophy. Int J Clin Pharmacol Ther. 2009; 47 Suppl 1:S128-31.
Score: 0.003